MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis

Breast Cancer Research

Volumn 14, Issue 3, 2012, Pages

  Hui, Chang ^a   Yujie, Fu ^a   Lijia, Yuan ^a   Long, Yi ^a   Hongxia, Xu ^a   Yong, Zhou ^a   Jundong, Zhu ^a   Qianyong, Zhang ^a   Mantian, Mi ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3,6 DIHYDROXYFLAVONE; ANTINEOPLASTIC AGENT; CYTOCHROME C; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; MICRORNA 21; MICRORNA 34A; UNCLASSIFIED DRUG; 3,6-DIHYDROXYFLAVONE; FLAVONOID; METHYLNITROSOUREA; MICRORNA; MIRN21 MICRORNA, RAT; MIRN34 MICRORNA, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INHIBITION; CANCER PREVENTION; CELL ASSAY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; DRUG BIOAVAILABILITY; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MITOCHONDRIAL MEMBRANE POTENTIAL; NICK END LABELING; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; DRUG EFFECT; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; SPRAGUE DAWLEY RAT; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROMES C; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY NEOPLASMS, ANIMAL; METHYLNITROSOUREA; MICE; MICE, INBRED BALB C; MICRORNAS; RATS; RATS, SPRAGUE-DAWLEY; TRANSPLANTATION, HETEROLOGOUS;

EID: 84861212776     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3194     Document Type: Article

References (35)

1. Han Y, Chen J, Zhao X, Liang C, Wang Y, Sun L, Jiang Z, Zhang Z, Yang R, Chen J, Li Z, Tang A, Li X, Ye J, Guan Z, Gui Y, Cai Z. MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 2011, 6:e18286. 10.1371/journal.pone.0018286, 3065473, 21464941.
2. Miller N, Kerin MJ. Circulating microRNAs: promising breast cancer biomarkers. Breast Cancer Res 2011, 13:402. (Letter), 3109560, 21345257.
3. Majid S, Saini S, Dar AA, Hirata H, Shahryari V, Tanaka Y, Yamamura S, Ueno K, Zaman MS, Singh K, Chang I, Deng G, Dahiya R. MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res 2011, 71:2611-2621. 10.1158/0008-5472.CAN-10-3666, 21330408.
4. Suh SO, Chen Y, Zaman MS, Hirata H, Yamamura S, Shahryari V, Liu J, Tabatabai ZL, Kakar S, Deng G, Tanaka Y, Dahiya R. MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis 2011, 32:772-778. 10.1093/carcin/bgr036, 3086703, 21349819.
5. Srivastava N, Manvati S, Srivastava A, Pal R, Kalaiarasan P, Chattopadhyay S, Gochhait S, Dua R, Bamezai RN. miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention. Breast Cancer Res 2011, 13:R39. 10.1186/bcr2861, 3219202, 21463514.
6. Pan X, Wang ZX, Wang R. MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol Ther 2011, 10:1224-1232.
7. Lou Y, Yang X, Wang F, Cui Z, Huang Y. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med 2010, 26:819-827.
8. Spike BT, Wahl GM. p53, stem cells, and reprogramming: tumor suppression beyond guarding the genome. Genes Cancer 2011, 2:404-419. 10.1177/1947601911410224, 3135646, 21779509.
9. Rodriguez R, Rubio R, Gutierrez-Aranda I, Melen GJ, Elosua C, García-Castro J, Menendez P. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells. Stem Cells 2011, 29:179-192. 10.1002/stem.571, 21732477.
10. Kim HR, Roe JS, Lee JE, Hwang IY, Cho EJ, Youn HD. A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH. Biochem Biophys Res Commun 2012, 418:682-688. 10.1016/j.bbrc.2012.01.077, 22301190.
11. Chen F, Hu SJ. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review. J Biochem Mol Toxicol 2012, 26:79-86. 10.1002/jbt.20412, 22162084.
12. Hui C, Bin Y, Xiaoping Y, Long Y, Chunye C, Mantian M, Wenhua L. Anti-cancer activities of an anthocyanin-rich extract from black rice against breast cancer cells in vitro and in vivo. Nutr Cancer 2010, 62:1-9.
13. Lee YC, Cheng TH, Lee JS, Chen JH, Liao YC, Fong Y, Wu CH, Shih YW. Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells. Mol Cell Biochem 2011, 347:103-115. 10.1007/s11010-010-0618-z, 20963626.
14. Yi L, Chen CY, Jin X, Mi MT, Yu B, Chang H, Ling WH, Zhang T. Structural requirements of anthocyanins in relation to inhibition of endothelial injury induced by oxidized low-density lipoprotein and correlation with radical scavenging activity. FEBS Lett 2010, 584:583-590. 10.1016/j.febslet.2009.12.006, 20004199.
15. Attoub S, Hassan AH, Vanhoecke B, Iratni R, Takahashi T, Gaben AM, Bracke M, Awad S, John A, Kamalboor HA, Al Sultan MA, Arafat K, Gespach C, Petroianu G. Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol 2011, 651:18-25. 10.1016/j.ejphar.2010.10.063, 21074525.
16. Chang H, Mi M, Ling W, Zhu J, Zhang Q, Wei N, Zhou Y, Tang Y, Yuan J. Structurally related cytotoxic effects of flavonoids on human cancer cells in vitro. Arch Pharm Res 2008, 31:1137-1144. 10.1007/s12272-001-1280-8, 18806956.
17. Chang H, Lin H, Yi L, Zhu J, Zhou Y, Mi M, Zhang Q. 3,6-DHF induces apoptosis in Leukemia HL-60 Cell via reactive oxygen species-mediated p38 MAPK/JNK pathway. Eur J Pharmacol 2010, 648:31-38. 10.1016/j.ejphar.2010.08.020, 20840847.
18. Chang H, Mi M, Ling W, Zhu J, Zhang Q, Wei N, Zhou Y, Tang Y, Yu XP, Zhang T, Wang J, Yuan J. Structurally related anticancer activity of flavonoids: involvement of reactive oxygen species generation. J Food Biochem 2010, 34:1-14.
19. Chen KS, Hsiao YC, Kuo DY, Chou MC, Chu SC, Hsieh YS, Lin TH. Tannic acid-induced apoptosis and -enhanced sensitivity to arsenic trioxide in human leukemia HL-60 cells. Leuk Res 2009, 33:297-307. 10.1016/j.leukres.2008.08.006, 18790533.
20. Chen Y, Liu W, Chao T, Zhang Y, Yan X, Gong Y, Qiang B, Yuan J, Sun M, Peng X. MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Lett 2008, 272:197-205. 10.1016/j.canlet.2008.06.034, 19013014.
21. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33:e179. 10.1093/nar/gni178, 1292995, 16314309.
22. Carlsen MH, Karlsen A, Lillegaard IT, Gran JM, Drevon CA, Blomhoff R, Andersen LF. Relative validity of fruit and vegetable intake estimated from an FFQ, using carotenoid and flavonoid biomarkers and the method of triads. Br J Nutr 2011, 105:1530-1538. 10.1017/S0007114510005246, 21272408.
23. Priyadarsini RV, Vinothini G, Murugan RS, Manikandan P, Nagini S. The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors. Nutr Cancer 2011, 63:218-226. 10.1080/01635581.2011.523503, 21294050.
24. Hannafon BN, Sebastiani P, de las Morenas A, Lu J, Rosenberg CL. Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res 2011, 13:R24. 10.1186/bcr2839, 3219184, 21375733.
25. Colak D, Chishti MA, Al-Bakheet AB, Al-Qahtani A, Shoukri MM, Goyns MH, Ozand PT, Quackenbush J, Park BH, Kaya N. Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old. Mol Cancer 2010, 9:146-165. 10.1186/1476-4598-9-146, 2898705, 20540791.
26. Feng YH, Wu CL, Tsao CJ, Chang JG, Lu PJ, Yeh KT, Uen YH, Lee JC, Shiau AL. Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: correlation with the clinical stage of the disease. Cancer Biol Ther 2011, 11:111-121. 10.4161/cbt.11.1.13965, 21099344.
27. Lee JA, Lee HY, Lee ES, Kim I, Bae JW. Prognostic implications of microRNA-21 overexpression in invasive ductal carcinomas of the breast. J Breast Cancer 2011, 14:269-275. 10.4048/jbc.2011.14.4.269, 3268922, 22323912.
28. Tomimaru Y, Eguchi H, Nagano H, Wada H, Tomokuni A, Kobayashi S, Marubashi S, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M. MicroRNA-21 induces resistance to the anti-tumour effect of interferon 5-fluorouracil in hepatocellular carcinoma cells. Br J Cancer 2010, 103:1617-1626. 10.1038/sj.bjc.6605958, 2990590, 20978511.
29. Tivnan A, Tracey L, Buckley PG, Alcock LC, Davidoff AM, Stallings RL. MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma. BMC Cancer 2011, 11:33-44. 10.1186/1471-2407-11-33, 3038978, 21266077.
30. Akao Y, Noguchi S, Iio A, Kojima K, Takagi T, Naoe T. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. Cancer Lett 2011, 300:197-204. 10.1016/j.canlet.2010.10.006, 21067862.
31. Bhatt K, Zhou L, Mi QS, Huang S, She JX, Dong Z. MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival. Mol Med 2010, 16:409-416. 2935954, 20386864.
32. Luan S, Sun L, Huang F. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Arch Med Res 2010, 41:67-74. 10.1016/j.arcmed.2010.02.007, 20470934.
33. Pang RT, Leung CO, Ye TM, Liu W, Chiu PC, Lam KK, Lee KF, Yeung WS. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 2010, 31:1037-1044. 10.1093/carcin/bgq066, 20351093.
34. Lee JH, Lu H. Chimeric p53 as an alternative therapy for hypoxic tumors. Cancer Biol Ther 2011, 11:108-110. 10.4161/cbt.11.1.14526, 3047102, 21189450.
35. Ray RM, Bhattacharya S, Johnson LR. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1. Apoptosis 2011, 16:35-44. 10.1007/s10495-010-0538-0, 20812030.